Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

Share Price is delayed by 15 minutes
Get Live Data
297.00    0.60 (0.20%)
Bid:
298.00
Ask:
298.60
Spread: 0.60 (0.201%)
Market Cap: £268.57m
FUTR Live PriceLast checked at - London Stock Exchange

Intraday Future Share Chart

Pre Stabilisation Notice

1 Jul 2025 11:21

RNS Number : 2309P
HSBC Bank plc
01 July 2025
Β 

1st July 2025

Β 

FutureΒ plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

FutureΒ plc

Guarantor (if any):

na

Aggregate nominal amount:

GBP 300,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

3rd July 2025

Stabilisation period expected to end no later than:

8th August 2025

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

Β 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

Β 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

Β 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involvedΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STAZZGGNGMGGKZM
Date   Source Headline
30th Mar 20233:20 pmRNSDirector Declaration
30th Mar 20237:00 amRNSCompany Secretary Change
13th Mar 20237:00 amRNSNo material exposure to Silicon Valley Bank
1st Mar 202310:04 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSHolding(s) in Company
22nd Feb 20237:00 amRNSAppointment of Jon Steinberg as CEO
14th Feb 20234:35 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20231:51 pmRNSResult of AGM
8th Feb 20237:00 amRNSAGM trading statement
7th Feb 20232:39 pmRNSHolding(s) in Company
3rd Feb 202311:10 amRNSHolding(s) in Company
31st Jan 20231:40 pmRNSTotal Voting Rights
11th Jan 20231:41 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSEBT share purchase
3rd Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 20232:27 pmRNSBlock listing Interim Review
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 20227:00 amRNSDirector/PDMR Shareholding
15th Dec 202210:51 amRNSAnnual Financial Report
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20229:57 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSFull Year Results
3rd Nov 202212:23 pmRNSDirector Declaration
31st Oct 20229:32 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20222:16 pmRNSHolding(s) in Company
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 202210:35 amRNSResponse to press speculation
15th Sep 20227:14 amRNSDirector Declaration
14th Sep 20227:00 amRNSCapital Market Event
13th Sep 20227:00 amRNSTrading Update
12th Sep 20227:00 amRNSDirector/PDMR Shareholding
31st Aug 20229:35 amRNSTotal Voting Rights
8th Aug 20228:32 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSNotice of Capital Markets Event
29th Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20228:27 amRNSTotal Voting Rights
30th Jun 20228:25 amRNSBlock listing Interim Review
17th Jun 20227:00 amRNSCompletion of Acquisition & Trading update
15th Jun 20221:19 pmRNSEBT share purchase
31st May 20228:24 amRNSTotal Voting Rights
25th May 20223:13 pmRNSHolding(s) in Company
25th May 20228:27 amRNSHolding(s) in Company
19th May 20228:12 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSHalf Year Results
12th May 202210:37 amRNSHolding(s) in Company
10th May 20227:00 amRNSAcquisition of WhoWhatWear
29th Apr 20229:49 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.